Oxcarbazepine Tablet
Product Images NDC 70771-1844

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70771-1844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (6a50f32f 6dab 4f67 B7ac 754cceea4299 01)

Chemical structure diagram of oxcarbazepine, an active pharmaceutical ingredient commonly used in oral tablets. The structure shows a dibenzazepine ring system with a ketone and a carboxamide group attached.*

FDA Label Image

Figure (6a50f32f 6dab 4f67 B7ac 754cceea4299 02)

A Kaplan-Meier survival curve showing exit rate over time from Day 2 to Day 11, comparing two treatment groups: Oxcarbazepine (solid line) and Placebo (dashed line). The y-axis represents exit rate from 0.0 to 1.0, and the graph includes a log-rank test p-value of 0.0001 indicating statistical comparison.*

FDA Label Image

Figure (6a50f32f 6dab 4f67 B7ac 754cceea4299 03)

A Kaplan-Meier survival curve chart depicting seizure rate over days from first dose to first seizure, comparing oxcarbazepine treatment (solid line) versus placebo (dotted line). The x-axis measures days from initial dose, and the y-axis shows the seizure rate. The chart includes a log-rank test p-value of 0.046.*

FDA Label Image

Figure (6a50f32f 6dab 4f67 B7ac 754cceea4299 04)

A Kaplan-Meier survival curve chart depicting exit rates over time in days for two treatment groups labeled 'HIGH' (solid line) and 'LOW' (dotted line). The vertical axis represents exit rate from 0.0 to 1.0, and the horizontal axis shows time to exit in days from 0 to 130. The chart includes a log-rank test p-value of 0.0001 comparing the groups.*

FDA Label Image

Figure (6a50f32f 6dab 4f67 B7ac 754cceea4299 05)

A Kaplan-Meier survival curve chart depicting exit rate over time to exit (days) for two treatment groups labeled as HIGH and LOW. The solid line represents the HIGH group, and the dotted line represents the LOW group. The chart includes a log-rank test p-value of 0.0001, indicating statistical comparison between groups.*

FDA Label Image

150mg Container Label (6a50f32f 6dab 4f67 B7ac 754cceea4299 06)

Label for Oxcarbazepine Tablets, USP 150 mg oral tablets, manufactured by Zydus Lifesciences Limited. Features a purple and gray color scheme with images of two oblong yellow tablets embossed with '6' and '91'. The package contains 100 tablets. Includes storage instructions, a pharmacist note, and warnings to keep out of children's reach.*

FDA Label Image

150mg Carton Label (6a50f32f 6dab 4f67 B7ac 754cceea4299 07)

Packaging label for Oxcarbazepine Tablets, USP 150 mg, oral tablets. The label shows the brand and generic name, strength (150 mg), and images of the tablets. It includes storage instructions (20° to 25°C), a note that this unit dose package is not child-resistant, quantity (100 tablets, 10 x 10 unit-dose), and is Rx only. The labeler is Zydus Lifesciences Limited, manufactured by Cadila Healthcare Ltd., India.*

FDA Label Image

300mg Container Label (6a50f32f 6dab 4f67 B7ac 754cceea4299 08)

Label for Oxcarbazepine Tablets, USP 300 mg oral tablets in a 100-tablet package by Zydus Pharmaceuticals, a division of Zydus Lifesciences Limited. The label includes the NDC 70771-1843-1, tablet images with imprint '69 92', storage instructions, and pharmacist dispensing information.*

FDA Label Image

300mg Carton Label (6a50f32f 6dab 4f67 B7ac 754cceea4299 09)

Packaging label for Oxcarbazepine Tablets USP, 300 mg oral dosage form by Zydus Lifesciences Limited. The label indicates a count of 100 tablets (10 x 10 unit-dose) and includes an image of two oval-shaped tablets. The label notes storage instructions, a pharmacist medication guide advisory, and manufacturing information from Cadila Healthcare Ltd., India.*

FDA Label Image

600mg Container Label (6a50f32f 6dab 4f67 B7ac 754cceea4299 10)

Label for Oxcarbazepine Tablets USP 600 mg oral tablets. The label shows two oval, light yellow tablets imprinted with "6 93". The package contains 100 tablets. The label includes storage instructions and cautions to keep out of reach of children. Manufactured by Cadila Healthcare Ltd., Baddi, India, and labeled by Zydus Pharmaceuticals.*

FDA Label Image

600mg Carton Label (6a50f32f 6dab 4f67 B7ac 754cceea4299 11)

Packaging label for Oxcarbazepine Tablets, USP 600 mg oral tablets, manufactured by Zydus Lifesciences Limited. The unit-dose box contains 100 tablets (10 x 10 unit-dose). Label includes images of two yellow oval tablets and storage, dosage, and safety information. The label notes the product is Rx only and not child-resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.